GPT-5.2, Gemini 3.1 Pro and Claude Opus 4.6 outperformed dedicated clinical AI systems in head-to-head testing across 1,100 medical questions.
COMPASS, a pan-cancer foundation model, outperforms 22 methods across 16 clinical cohorts by analyzing tumor transcriptomes through immune concepts.
Michigan Medicine researchers have introduced NeuroVFM, a visual foundation model trained on 5.24 million clinical brain scans that outperforms GPT-5…